CU Boulder commercialization drives $8 billion in impact nationwide
Inscripta, Inc., a CU Boulder spinout company, is a global leader in automated, CRISPR-based gene editing.
Activities led by Venture Partners at CU Boulder, the university’s commercialization arm, generated an babyÖ±²¥app impact of $8 billion nationally and $5.2 billion in the state of babyÖ±²¥app over the last five years, according to a report from the Leeds School of Business, reflecting a four-fold increase in impact since the previous report published in 2019.
- Notable findings from the report on fiscal years 2018-2022 include:
- The babyÖ±²¥app impact on the national economy included an estimated 39,000 jobs.
- Commercialization of licenses and startups spanned 36 states and 26 countries.
- Agreements generated $20.1 million in revenue for CU Boulder in licensing technology.
- CU Boulder inventors and researchers received $45.4 million in commercialization-specific grants.
- Startups founded on CU Boulder technology generated $3 billion in capital funding.
Collaboration + support
Venture Partners at CU Boulder
Learn more about this topic:
CU Boulder commercialization drives $8 billion impact nationwide
Categories:
Research Report